GDF6, a Novel Locus for a Spectrum of Ocular Developmental Anomalies  by Asai-Coakwell, Mika et al.
306 The American Journal of Human Genetics Volume 80 February 2007 www.ajhg.org
ARTICLE
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Colobomata represent visually impairing ocular closure defects that are associated with a diverse range of developmental
anomalies. Characterization of a chromosome 8q21.2-q22.1 segmental deletion in a patient with chorioretinal coloboma
revealed elements of nonallelic homologous recombination and nonhomologous end joining. This genomic architecture
extends the range of chromosomal rearrangements associated with human disease and indicates that a broader spectrum
of human chromosomal rearrangements may use coupled homologous and nonhomologous mechanisms. We also dem-
onstrate that the segmental deletion encompasses GDF6, encoding a member of the bone-morphogenetic protein family,
and that inhibition of gdf6a in a model organism accurately recapitulates the proband’s phenotype. The spectrum of
disorders generated by morpholino inhibition and the more severe defects (microphthalmia and anophthalmia) observed
at higher doses illustrate the key role of GDF6 in ocular development. These results underscore the value of integrated
clinical and molecular investigation of patients with chromosomal anomalies.
From the Departments of Ophthalmology (M.A.-C.; M.Y.; O.J.L.), Biological Sciences (C.R.F.; K.M.B.; R.K.; A.J.W.), and Medical Genetics (M.A.-C.; M.Y.;
M.S.; R.M.; O.J.L.), University of Alberta, Edmonton; and Medical Research Council Human Genetics Unit, Edinburgh (V.v.H.)
Received July 31, 2006; accepted for publication November 28, 2006; electronically published December 29, 2006.
Address for correspondence and reprints: Dr. Ordan J. Lehmann, Departments of Ophthalmology and Medical Genetics, 8–29 Medical Sciences Building,
University of Alberta, Edmonton, Alberta, Canada T6G 2H7. E-mail: olehmann@ualberta.ca
* These two authors contributed equally to this work.
Am. J. Hum. Genet. 2007;80:306–315.  2006 by The American Society of Human Genetics. All rights reserved. 0002-9297/2007/8002-0011$15.00
Normal ocular development entails a series of tightly cho-
reographed events, of which fusing the edges of the optic
cup’s embryonic fissure represents a key step in forming
the future spherical eye. Disruption of this process results
in colobomata (MIM 120200)—congenital anomalies af-
fecting tissues in the posterior (retina, choroid, and optic
nerve) and anterior (cornea, iris, and lens) ocular seg-
ments. Colobomata may, in turn, cause abnormal mor-
phogenesis of other ocular tissues, because of the retina’s
inductive role in lens formation. Consequently, colobo-
mata are frequently associated with ocular malformations,
including cataract, microphthalmia, and anophthalmia;
systemic anomalies—such as renal anomalies, mental re-
tardation, and CHARGE (coloboma, heart defects, choanal
atresia, retarded growth, and genital and ear anomalies
[MIM 214800])1—are also observed in a small subset.
Causal mutations for coloboma have been identified in
only a small number of cases, and the genetic heteroge-
neity (OTX2 [MIM 600037],2 SHH [MIM 600725],3 MAF
[MIM 177075],4 CHX10 [MIM 142993],5 CHD7 [MIM
608892],6,7 and PAX6 [MIM 607108]8) reflects the diverse
molecular interactions that control eye development. Al-
though autosomal dominant, recessive, and X-linked in-
heritance9–11 of colobomata are observed, the absence of
clear Mendelian inheritance patterns indicates the pres-
ence of a less straightforward molecular basis in some
cases.2,12,13 Increasing the proportion of colobomata with
a defined genetic origin would benefit the understanding
of complex disease and provide novel insight for ocular
development and may identify therapeutic targets for a
frequently blinding disorder.
Colobomata are associated with rearrangements affect-
ing at least 10 autosomes,3–6,8,12,14–17 including several syn-
dromes, such as CHARGE,7,6 “Cat eye” syndrome (MIM
115470),17,18 Jacobsen syndrome (MIM 147791),19 and Wolf-
Hirschhorn syndrome (MIM 194190).16 Study of chromo-
somal anomalies has proved a fruitful means of identi-
fying dosage- or position effect–sensitive genes, particu-
larly for ocular disorders, since research is facilitated by
the fact that the eye is composed of an interface of em-
bryonically distinct tissues and by accessibility to detailed
phenotyping.20–23 Detection of a segmental deletion syn-
tenic with the murine ocular malformation locus Tcm24,25
in a patient with colobomata enabled us to investigate the
cause of the ocular developmental phenotype and the
mechanism mediating this chromosomal rearrangement.
Observation of features of nonallelic homologous recom-
bination (NAHR) and nonhomologous end joining (NHEJ)
in this segmental deletion extend the range of chro-
mosome rearrangements associated with human disease.
Analyses of genes within and adjacent to the segmental
deletion led us to identify growth differentiation factor 6
(GDF6 [MIM 601147]) as a candidate gene for the patient’s
ocular phenotype. Morpholino inhibition of the func-
tion of gdf6 in zebrafish, performed to evaluate this gene’s
role in retinal development, recapitulated the patient’s
phenotype.
Material and Methods
Patients
Peripheral-blood samples were obtained from a family in which
ocular and systemic developmental anomalies had been identi-
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Table 1. Primers Used to Amplify the Chromosome 8q22 Junctional Fragment and
for RT-PCR of Murine and Zebrafish gdf6
Analysis
Primer
(5′r3′)
Annealing
Temperature
(C)Forward Reverse
Fragment:
F2-R3 CCATGACGTGTGAAACCAAC TCATTGGTCTGGGTAGAGC 60
Chromosome 8-4 AGGCACAACAGGAAATGAAGTT GTTGACACTCCTTCCCTCCA 60
Chromosome 8-5 GAAGCACTTACATCAGCACCTG GACCCCATCTCTTATTCTTGCTT 60
Chromosome 8-6 TAGGCTGCCTGAGTGTCCTT GGTTCGTGGTCTCACTGGTT 60
RT-PCR:
Murine GCGCGTGGTGCCTCACGAGTAC GGGGCGCGATAATCCAGTCGTC 60
Zebrafish CGCGGTCCAAGAAGAGAGAGAACTT GCGCGTCTTTACGCATCGTTCAAGT 60
gdf6a GTGAGACACGGCTCCACTTTACTC GAAGGTTGTAGACGCCTGATGGGG 55
fied in one individual. In view of the breadth of the phenotype,
karyotyping of the proband and her parents was undertaken, to-
gether with subsequent multiplex-FISH (M-FISH) analysis. This
study was approved by the University of Alberta Hospital Health
Research Ethics Board, and informed consent was obtained from
all participants.
Defining the Segmental Deletion
After initial karyotyping (at the University of Alberta Hospital
Cytogenetics Laboratory) revealed a chromosome 8q segmental
deletion, M-FISH was undertaken using region-specific and par-
tially overlapping chromosome probes (mBAND X Cyte8 probe
set [MetaSystems]).26 Each contains a unique fluorochrome, which
permits quantitative analysis of fluorescence intensity along a
chromosome. The deletion’s extent was next refined by fluores-
cent microsatellite-marker genotyping (centromeric: D8S1697,
D8S1702, D8S1838, D8S461, D8S1912, and D8S1119; telomeric:
D8S1699, D8S1127, D8S1772, D8S1129, and D8S1778). Subse-
quently, comparative genomic hybridization (CGH) was per-
formed with a custom array comprising isothermal, long oligo-
nucleotide probes tiled at a 5-kb density across the repeat-masked
genomic interval encompassing the segmental deletion (Nimble-
gen). The mean probe density was increased to 1 kb in regions
predicted by microsatellite-marker genotyping to correspond to
the centromeric and telomeric breakpoints. CGH was performed
as described elsewhere,27 with use of the proband’s DNA labeled
with Cy3, hybridized with a Cy5-labeled reference DNA.
Amplification of the Junctional Fragment
Guided by the CGH results and bioinformatic sequence informa-
tion, multiple primer pairs were designed to amplify a junctional
fragment that spanned the segmental deletion. One of these nine
primer permutations (F2-R3) yielded an amplicon in the proband,
through use of long-range PCR (Elongase [Invitrogen]), which was
purified with Montage (Millipore) and was sequenced using these
and internal primers (table 1), with a BigDye (v3.1) terminator
kit and 3100 DNA sequencer (Applied Biosystems). Subsequent
in silico analyses of the sequence adjacent to the breakpoint were
performed with Ensembl, University of California–Santa Cruz
(UCSC), and National Center for Biotechnology Information
(NCBI) Entrez genome browsers. Through use of BLASTn (NCBI
BLAST),28 homologous sequences adjacent to the breakpoint were
identified, and the boundaries of the repeat elements were de-
termined using PipMaker29 and Ensembl, UCSC, NCBI Entrez, and
NCBI BLAST.
Bioinformatic and Expression Analyses
Database analyses of genes lying in the deleted region or adjacent
to the breakpoints were performed to identify candidate(s) for
the ocular phenotype (Ensembl, UCSC, and UniGene). FISH was
also undertaken with the BAC clone RP11-516P9, to validate da-
tabase predictions. The expression of one gene (GDF6) was in-
vestigated by RT-PCR of murine (adult and embryonic) and ze-
brafish (18 and 42 h postfertilization [hpf]) tissue (through use
of primers shown in table 1 and Superscript III RT-PCR [Invitro-
gen]). Ethidium bromide–stained amplicons were visualized on
1% agarose gels. Whole-mount in situ hybridization was under-
taken using digoxigenin-labeled antisense RNA probes specific to
retinal developmental genes that are primarily markers of region-
al identity. cDNA from hmx3b (nkx5.1/soho1), aldh1a2 (raldh2),
and foxg1 were generated, and in situ hybridization was per-
formed as described elsewhere30 on wild-type and gdf6a-mor-
phant zebrafish.
Analysis of gdf6a Function in Zebrafish
Zebrafish possess two orthologues, gdf6a (radar) and gdf6b (dy-
namo),31 with gdf6a expressed in developing retina, dorsal fin,
dorsal neural tube, and posterior endoderm.32,33 Zebrafish embryos
have two sources of gdf6a: unspliced zygotic and prespliced ma-
ternal gdf6a mRNA. Morpholino inhibition of zebrafish zygotic
gdf6a function results in cranial and dorsal neural-tube apoptosis,
whereas inhibition of both maternal and zygotic gdf6a (with a
translation-blocking morpholino) generates an earlier dorsalized
phenotype, thereby preventing analysis of eye development.34
Accordingly, two splice-blocking morpholino antisense oligo-
nucleotides (MOs) were designed to independently target gdf6a
splicing, which enables comparison of the phenotype generated
by each. The first (gdf6aMO1) targets the 5′ splice site, whereas the
second (gdf6aMO2) targets the intron 1–exon 2 boundary. Addi-
tional morpholinos were designed to target the translation start
site of gdf6b (gdf6bMO) and to provide a capability to reduce ap-
optotic cell death to the translation start site of p53 (p53MO). Ol-
igonucleotides gdf6aMO1 (GCAATACAAACCTTTTCCCTTGTCC),34
gdf6aMO2 (GAGATCGTCTGCAAGATAAAGAGAA), and p53MO
(GCGCCATTGCTTTGCAAGAATTG)35 were provided by Gene
Tools; gdf6bMO (TCAAAAGTATCCCGCAGGCACACAT) was pro-
vided by Open Biosystems. The efficiency of the two gdf6a mor-
pholinos was evaluated by RT-PCR of mRNA derived from 18-hpf
uninjected and morphant embryos, by use of gdf6a primers span-
ning the intron (table 1). Zebrafish (AB strain) were obtained from
the zebrafish stock center ZIRC and were maintained under stan-
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dard conditions. Morpholino (2–4 nl) was injected into one-cell–
stage zebrafish embryos, at a concentration of 2.5 mg/ml, as de-
scribed elsewhere.36 All injections of gdf6a morpholino included
3 ng of p53MO to reduce apoptotic cell death, a known side effect
of morpholino injection. Morphological observations were made
with an Olympus SZX12 stereomicroscope and were recorded us-
ing a Qimaging micropublisher digital (charged-couple device)
camera. For histological analysis, larvae were fixed in a 2.5% glu-
taraldehyde, 1% paraformaldehyde mix, followed by 4% osmium
tetroxide, embedded in Epon, and a thin (1 mm) section cut with
an ultramicrotome. Richardson’s and phalloidin stains were used
to visualize structural details within the retina and surrounding
tissues.
Results
Phenotype
The proband exhibited multiple developmental defects,
including neurodevelopmental impairment (performance
IQ 74), bilateral soft-tissue syndactyly of the 2nd and 3rd
toes, an atrial septal defect, and ocular malformations (fig.
1). The latter comprised bilateral retinochoroidal colobo-
mata with optic-nerve involvement (fig. 1A and 1B), plus
a unilateral iris coloboma (fig. 1C), which reduced vision
to counting fingers and 20/50 in the right and left eyes,
respectively. Although the proband’s father was asymp-
tomatic, ocular examination revealed features of much
milder developmental defects that included a minor de-
gree of optic-nerve dysplasia, anomalous retinal vascular
branching, and small retinochoroidal colobomata (fig. 1G
and 1H). The changes were associated with corrected acu-
ities of 20/202 and 20/30 (normal ∼20/20).
Fine Mapping and Sequencing of Breakpoint
Karyotyping identified a chromosome 8q segmental dele-
tion—46,XX, del (8)(q21.2q22.1)—in the proband but in
neither parent (data not shown). These findings were con-
firmed by M-FISH, with the segmental deletion present in
all 13 examined metaphase preparations (fig. 1J–1L). The
informativeness of microsatellite-marker genotyping was
constrained by the small pedigree size and polymorphism-
information-content values of available markers. None-
theless, it confirmed that the deletion was present in the
paternally derived chromosome 8, and the semiquantita-
tive dosage information it provided localized the centro-
meric and telomeric breakpoints to ∼3-Mb regions. CGH
accurately defined the extent of the segmental deletion
(10.37 Mb) and refined the breakpoint positions to ∼10-
kb intervals (data not shown). Long-range PCR amplified
a 4.5-kb junctional fragment in the proband but in neither
parent (fig. 2C). Sequence analysis of the junctional frag-
ment revealed the insertion of four nucleotides (AGCT) at
the junction of the centromeric and telomeric breakpoints
(fig. 2A and 2B). The telomeric breakpoint lies in a long
terminal repeat (LTR) of family MaLR, within a 3.6-kb re-
gion of repetitive sequence (fig. 2A). The centromeric
breakpoint is within an Alu element located within a 5.7-
kb stretch of contiguous repeats (short interspersed nu-
clear elements [SINEs], long interspersed nuclear elements
[LINEs], LTRs, and simple repeats).
Candidate-Gene and Mutation Analysis
The proband’s retinal phenotype and the known molec-
ular conservation of ocular development were used to
identify candidate genes in silico. Of 31 genes within and
10 adjacent to the segmental deletion, 14 were expressed
in both fetal eye and retinal tissue, and, of these, 11 (CA2,
CA3, WWP1, NBN, FAM82B, TMEM64, TMEM55A, UQCRB,
PTDSS1, SDC2, and GDF6) had orthologues present in
Fugu or Danio. Because of its involvement in bone morpho-
genetic protein (BMP) signaling, its developmental role,
and the location of Gdf6 within the Tcm locus,24 GDF6 was
selected for more-detailed study. Subsequent refinement
of the Tcm locus from a 26-Mb24 to a 1.3-Mb25 interval
permitted comparison of the five genes or transcripts (un-
known, helicase-related, Cralbp-related, Asph, and Gdf6)
within the Tcm locus with those encompassed by the seg-
mental deletion. Because of a synteny break between hu-
man chromosome 8 and murine chromosome 4, Gdf6/
GDF6 is the only gene common to the Tcm and chromo-
some 8q segmental deletion intervals (fig. 2D).
Studies of gdf6a in Zebrafish
Previous studies have examined the role of gdf6a in early
dorsal-ventral axis formation, but its function during ret-
inal development remains to be elucidated. The expression
of zebrafish gdf6a was examined with in situ hybridization
and was shown to be specific for the dorsotemporal region
of the developing retina at 18 and 24 hpf (fig. 3A and
3B). The expression pattern of Gdf6 is evolutionarily con-
served, as determined by our RT-PCR results of murine
retina during early development and the published ex-
pression in the dorsal retina of Xenopus37 (data not shown).
Splice-blocking gdf6a morpholinos were injected into one-
cell–stage zebrafish embryos; RT-PCR confirmed that 170%
of gdf6a mRNA was aberrantly spliced in both gdf6aMO1-
and gdf6aMO2-injected morphants (fig. 3C). Morpholino in-
hibition of gdf6a function revealed the axial vasculature,
dorsal fin, hypochord, and dorsal neural-tube anomalies
(reported elsewhere32,33). In situ hybridization with probes
to aldh1a2, hmx3b, and foxg1 demonstrated that gdf6a
morpholinos profoundly altered retinal patterning (fig.
3D–3L). Expression of aldh1a2, a marker of dorsotem-
poral retina, was completely eliminated in 90% and 97%
of gdf6aMO1- and gdf6aMO2-injected embryos, respectively
( ) (fig. 3D–3F). Expression of hmx3b, an earlynp 113
marker of dorsal retina, was strongly reduced in 81% and
85% of gdf6aMO1- and gdf6aMO2-injected embryos, respec-
tively ( ) (fig. 3G–3I). In contrast, expression ofnp 110
foxg1, a marker of ventral-nasal retina, was expanded in
77% and 88% of gdf6aMO1- and gdf6aMO2-injected embryos,
respectively ( ) (fig. 3J–3L). Lenticular expressionnp 118
of hmx3b was unaltered in morphant embryos (fig. 3G–
3I). Overall, these results demonstrate that gdf6a functions
Figure 1. A–F, Phenotypes of proband with chromosome 8q segmental deletion who has colobomatous developmental anomalies
affecting the anterior and posterior ocular segments (A). Note the junction between the normal and abnormal retina. B, Retinochoroidal
colobomata, with extensive optic nerve involvement. C, Iris coloboma (right eye). D, Normal optic nerve and retina (for comparison).
E and F, Syndactyly affecting the 2nd and 3rd toes. G–I, Phenotypes of the proband’s father, demonstrating milder ocular colobomata
and syndactyly. G, Dysplastic optic nerve with anomalous vascular pattern and small inferior retinochoroidal coloboma. H, Similar but
milder changes (left eye). I, Soft-tissue syndactyly. M-FISH and summary of microsatellite marker genotyping results confirmed chro-
mosome 8q segmental deletion and approximate breakpoint positions. J, 4′,6-Diamidino-2-phenylindole staining demonstrating length
difference between the undeleted and the segmentally deleted chromosome. K, Merged fluorescence signals from five M-FISH probes
illustrating the segmental deletion. L, “False color” counterstaining, to illustrate with greater clarity the effect of the segmental deletion
on length of chromosome 8q. M, Montage illustrating normal hybridization pattern for each probe, decreased hybridization for diethy-
lamino-coumarin (DEAC) and SpO, the approximate extent of the segmental deletion (dotted blue line), and the microsatellite markers
used to refine the breakpoint position. Undeleted markers are shown in bold, deleted markers are underlined, and uninformative markers
are shown in plain type.
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Figure 2. A, Schematic representation of the proband’s segmental deletion, with coordinates of the centromeric and telomeric break-
points shown above the representation. GDF6 is located at positions 97223736–97244196. B, Sequence of junctional fragment comprising
TCCTGG from the centromeric end, fused to a 4-bp insertion (AGCT), and AGGTTT from the telomeric breakpoint 110 million bp away.
The repetitive sequences adjacent to the breakpoints comprise 5.7 kb of repeats centromerically and 3.6 kb of repeats telomerically.
(Some repeats extend beyond the depicted region.) C, Amplification of a 4.5-kb deletion-junction fragment in the proband that is not
present in the unaffected parents (1.7-kb control fragment amplified in all subjects). Fp father; Mp mother; Pp proband. D, Murine
Tcm locus on chromosome 4, a 1.17-Mb region encompassing five genes (A p unknown; B p helicase-related; Cp Cralbp-related; Dp
Asph; E p Gdf6) and their orthologues on human chromosome 8. Because of a synteny break, four genes are ∼35 Mb centromeric to
the segmental deletion, with only GDF6 common to both.
to specify dorsotemporal retinal identity and to repress
ventronasal identity.
In addition, as is evident (fig. 4), gdf6a morphants ex-
hibit a range of ocular anomalies that recapitulate the pa-
tient phenotype (fig. 1). These features, apparent as early
as 18 hpf, include ventral colobomata (35%; , atnp 214
48 hpf), persistent dorsal-retinal groove (17%; , atnp 214
48 hpf), and decreased ocular and lenticular size (30%;
, at 48 hpf) (figs. 4A, 4B, and 5). In contrast to thenp 214
declining proportion of morphants observed with colo-
bomatous defects at later stages (ventral coloboma [10%
at 72 hpf], dorsal-retinal groove [2% at 72 hpf] [fig. 4A–
4D]), the frequency of lens extrusion and microphthalmia
(9% and 60%, respectively, at 120 hpf) increased over time
(figs. 4E–4H and 5). Injection of higher doses of gdf6a mor-
pholino cause ocular regression to vestigial structures that
resemble human anophthalmia (fig. 4H). To investigate ret-
inal development at the cellular level, we examined gdf6a
morpholino–treated zebrafish embryos histologically.This
revealed a consistent reduction in ocular, lenticular, and
retinal size, together with prominent defects in both ret-
ina and lens (fig. 4I–4L). Although all cell types are visi-
ble, the retina is disorganized, indicating a critical role for
gdf6a in regulating neural retina cell behavior. Further-
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Figure 3. A and B, In situ analysis of gdf6a expression in developing wild-type zebrafish embryos at 18 and 24 hpf. C, RT-PCR used
to measure spliced gdf6a transcripts from uninjected (WT), gdf6aMO1-injected (MO1), and gdf6aMO2-injected (MO2) embryos, illustrating
reduced levels of spliced RNA product in morphant embryos. No change is noted in expression of ef1a in either MO1- or MO2-injected
embryos. Retinal and lens differentiation was evaluated by examining expression of marker genes in the developing retina at 24 hpf.
Expression of aldh1a2 (D–F) in the dorsal-temporal retina is eliminated in embryos injected with either gdf6a morpholino. Similarly,
expression of hmx3b (G–I) in the dorsal retina is strongly reduced in gdf6a morpholino–injected embryos. Expression of hmx3b in the
developing lens is largely unaffected in gdf6a morphants (G–I). Analysis of the nasal marker foxg1 (J–L) was expanded posteriorly to
more temporal retinal regions in gdf6a morphants. Red brackets highlight the extent of retinal gene expression. Embryos are mounted
in dorsal view, with the anterior to the left.
more, we find that the optic nerve is hypoplastic and oc-
casionally absent in morphant embryos (10% of embryos
are affected) (fig. 4J and 4L). In stark contrast to our results
with gdf6a/radar, inhibition of gdf6b/dynamo function re-
vealed no ocular phenotype, which clearly demonstrates
the specific role of gdf6a in ocular morphology.
Discussion
Although colobomata represent a relatively common de-
velopmental anomaly (2.6 in 10,000 births)38 that account
for up to 11% of pediatric blindness,1 knowledge of the
genetic basis remains limited. The identification of addi-
tional colobomata-causing genes is thus of value; it im-
proves the understanding of function in both normal de-
velopment and disease and provides the realistic prospect
of elucidating non-Mendelian pathways that contribute
to ocular-disease phenotypes. The present study charac-
terizes a novel chromosomal anomaly associated with oc-
ular colobomata, provides strong evidence of the key role
of GDF6 in ocular development, and illustrates the inter-
related nature of several ocular-disease phenotypes.
GDF6 is a member of the BMP subfamily of transforming
growth factor-beta (TGFb) signaling ligands, which are in-
volved in the creation of dorsal-ventral axes, specification
of neural crest, bone formation, and organogenesis.39,40
Evidence of involvement of BMP proteins in retinal de-
velopment is provided by the laminar organization and
retinal axon pathfinding defects caused by overexpression
of the BMP inhibitor gremlin.41 However, despite studies
of model organisms, the role of BMP signaling in retinal
development remains insufficiently characterized, and, in
particular, the contribution that BMP mutations make to
human ocular disease has not been determined.
Ascribing phenotypic causation to a single candidate
gene in a large deleted interval presents challenges. Ac-
cordingly, a variety of techniques—including CGH dele-
tion mapping, expression analysis, and study of a zebrafish
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Figure 4. Larval zebrafish retinal defects, caused by injection of splice-blocking gdf6a morpholinos. Wild-type images at 48 hpf (A)
and 72 hpf (C), compared with morphant counterparts (B and D). Decrease in lenticular and ocular size is evident at later stages (C
and D). Ventral colobomata and dorsal groove are highlighted in panel B (arrows). E–H, Images of 5-dpf zebrafish larvae, illustrating
phenotypic variability observed with higher doses (10 ng) of gdf6a morpholino (injected at the one-cell stage). E, Uninjected control.
F, Milder phenotype, with unilateral coloboma and lenticular extrusion. G, Unilateral coloboma and microphthalmia. H, Severe retinal
degeneration, resembling human anophthalmia. Transverse histological sections from wild-type (I and K) and gdf6a morphant (J and
L) 3-d-old embryos, with use of phalloidin-Alexa488 and Richardson’s stains. Phalloidin-stained images are composites of 12 equally
spaced 1-mm sections throughout the eye (I and J). Note reduction in ocular and lenticular size, loss of normal retinal lamination, and
vacuolation of the lens that protrudes anteriorly (L). Scale bar p 100 mm.
model of reduced gdf6a function—were undertaken, which
indicate GDF6’s responsibility for the ocular malforma-
tions. Gdf6/gdf6’s expression is temporally and spatially
appropriate for a developmental retinal phenotype, and
support for its involvement in the observed eye pheno-
types is provided by its role in ventral patterning23—a pro-
cess that, when disrupted by SHH mutations, also results
in colobomata.3 This accords with decreased GDF6 copy
number (figs. 1 and 2), the eye’s exquisite sensitivity to
altered gene dosage,23,42–46 the precise dosage requirement
of TGFb-signaling ligands, and the results of gdf6a-mor-
pholino inhibition.
To validate these findings, gdf6 gene function was in-
hibited in a zebrafish model. The recapitulation of the
proband’s phenotype—which generated posterior (dorsal
or retinochoroidal) and anterior segment (ventral or iris)
colobomata as well as microphthalmia—verifies the key
role of gdf6 and GDF6 in ocular development. The spec-
ificity of these effects is demonstrated by the unaffected
lens expression of hmx3b, decreased retinal expression of
aldh1a2 and hmx3b, and expanded retinal expression of
foxg1 (fig. 3), plus the phenotypic spectrum induced by
progressively higher morpholino doses (microphthalmia
and posterior-segment colobomata, anterior-segment col-
obomata, and, finally, anophthalmia) (fig. 4). Furthermore,
observation of retina-specific defects at a stage (18 hpf)
before retinal vascularization precludes the ocular phe-
notypes being attributable to nonspecific effects, such as
morpholino-induced retinal hypovascularization. Finally,
existence of the irradiation-induced Tcm mutant, mapping
to a small interval containing Gdf6, complements the hu-
man and zebrafish phenotypes. In view of the fact that
only Gdf6/GDF6 is present in both the Tcm and segmen-
tally deleted intervals and that Gdf6-coding mutations
were not observed in Tcm mice,25 the possibility that Tcm
is allelic and attributable to a segmental anomaly affecting
a Gdf6 regulatory element should be critically evaluated.
Tcm mice have multiple ocular phenotypes but none of
the proband’s syndromic features. In contrast, of the two
murine Gdf6/ strains generated, one has only skeletal
features described,47 whereas the other exhibits both skel-
etal and ocular anomalies (Mouse Genome Informatics
[accession number MGI:3604391]), which provides con-
firmation of the role of gdf6, Gdf6, and GDF6 in eye
development.
The effects of zebrafish gdf6a inhibition illustrate the
interrelated nature of certain ocular phenotypes. In pa-
tients, failure of embryonic fissure closure is associated
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Figure 5. Quantitative ocular phenotypic data from wild-type and
gdf6a morphant (5 ng gdf6aMO1 plus 3 ng p53MO) embryos at 2–5
dpf.
with variation in ocular size, including microphthalmia,
axial length !20 mm (normal 23.5 mm), and anophthal-
mia (absent eyes or rudimentary ocular remnants). Com-
plementing these clinical observations, in our zebrafish
model, more-severe phenotypes were induced with pro-
gressively lower gdf6 levels. In addition to the ocular anom-
alies, the syndactyly accords with the identical phenotype
generated by mutation in the BMP-antagonist NOGGIN48
and Gdf6’s role in skeletal development, where null gdf6
mutations cause carpal and tarsal bone fusion.47 The same
but milder phenotypes present in the proband’s father
could be compatible with gonosomal mosaicism or chro-
mosomal inversion, and future cytogenetic analyses may
differentiate between these possibilities.
Segmental deletions (and duplications) are usually gen-
erated by low-copy repeats (LCRs) that provide a substrate
for NAHR. Less frequently, NHEJ is responsible, and such
rearrangements are characterized by insertion of additional
bases at the junction and at breakpoints lying within Alu
elements or LINEs. The segmental deletion identified in
this study exhibits features of both mechanisms. The pres-
ence of LTRs on both sides of the deletion indicates in-
trachromosomal NAHR, whereas the breakpoint’s centro-
meric end’s location in an Alu, together with insertion of
4 bp, suggests NHEJ. The combination of NAHR and NHEJ
has recently been reported in X-chromosomal segmental
duplications.49,50 Observation of NAHR and NHEJ with a
segmental deletion extends the range of chromosome re-
arrangements associated with human disease and indi-
cates that a broader spectrum of human chromosomal
rearrangements may use coupled homologous and non-
homologous mechanisms.
In summary, it is evident that GDF6 has an essential
role in retinal development and that altered gene dosage
results in a diverse spectrum of ocular malformations. The
human and zebrafish phenotypes confirm interspecies con-
servation of the requirement for precise GDF6/gdf6 dosage
in normal development. The studies we have undertaken
so far have identified genetic variants that cause substan-
tial functional defects. These ocular phenotypes range
from optic-nerve hypoplasia to coloboma/microphthal-
mia and anophthalmia, which raises the possibility that
milder sequence changes contributing to other pheno-
types remain to be determined. Availability of zebrafish
and murine models, especially Gdf6/ mice in which de-
tailed analysis of the retina has yet to be reported,47 will
facilitate testing of this hypothesis. Equally exciting is the
potential for determining the phenotypes associated with
reciprocal chromosomal anomalies, exogenous gdf6’s abil-
ity to rescue induced phenotypes, and the role of other
members of the same clade in ocular development and
disease. Such investigations, which are just beginning,
stem from clinical observation51,52 of a broader phenotype
in a patient with chorioretinal colobomata and may im-
prove understanding of and the outcome for a frequently
blinding disorder.
Note Added in Proof.—While this manuscript was under
314 The American Journal of Human Genetics Volume 80 February 2007 www.ajhg.org
review, Hanel and Hensey53 demonstrated inhibition of
Xenopus gdf6 results in ocular developmental phenotypes,
providing further confirmation of this gene’s important
role in vertebrate eye development.
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